Cyclin-Dependent Kinase 4/6 Inhibitors, Margetuximab, Trastuzumab Deruxtecan, and Tyrosine Kinase Inhibitors Have Shown Promising Results
William Ray Stevens, PharmD Candidate
Advertisement
Articles by William Ray Stevens, PharmD Candidate
Advertisement
Latest Updated Articles
What Are the Newest Breast Cancer Treatment Options?September 22nd 2019
Advertisement
Advertisement
Trending on Pharmacy Times
1
CagriSema Outperforms Semaglutide in Lowering HbA1C, Reducing Weight Across REIMAGINE Trials
2
Drug Shortages Are Declining, But Persistent Supply Chain Vulnerabilities Continue to Threaten Access
3
The Peptide Surge: Counseling Guidance on GLP-1s, Compounded Therapies, and What Patients Want to Know
4
From Confusion to Clarity: Nadia Ahmad, PharmD, Highlights the Vital Role of the 2026 OTC Guide
5